Pharmacologic Therapy for Heart Failure - 2023
TUESDAY, February 21, 2023
12:15pm, Zoom Internet Activity
PHARMACOLOGIC THERAPY FOR HEART FAILURE - 2023
THE CORE OF THE “CORE FOUR”:SGLT-2 INHIBITION + SACUBITRIL/VALSARTAN
RICHARD F. WRIGHT, MD, FAAC
CHAIRMAN, PACIFIC HEART INSTITUTE, SANTA MONICA
DIRECTOR, ECHOCARDIOGRAPHY LAB, PROVIDENCE SAINT JOHN’S HEALTH CENTER
CO-CHAIR, HEART FAILURE CLINICAL SPECIALTY COMMITTEE,
PROVIDENCE SAINT JOSEPH HEALTH SYSTEM
CARDIOLOGY ADVISOR, MEDICARE RELATIVE VALUE UPDATE COMMITTEE
CO-CHAIR, MEDICARE PHYSICIAN ADVISORY COMMITTEE, CALIFORNIA
Planner/Moderator: Daniel Eisenberg, MD, Medical Director, Cardiac Services, PSJMC
FACULTY/PLANNER DISCLOSURES: It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Eisenberg discloses he has had no financial relationships nor affiliations with any ineligible companies in the past 24 months. Dr. Wright discloses he is on the Speakers Bureau and/or a consultant for Bristol-Myers Squibb, Boehringer-Ingelheim, Lilly, Pfizer, Amgen, and Novartis. It is our policy to review presentations ahead of time to mitigate any potential conflicts of interest. There were no conflicts identified in Dr. Wright’s presentation. Disclosures for members of the Medical Education Committee may be found on the CME website at www.providencecme.org.
Learning Objectives
Release Date: 4-21-23
Review Date: 4/26
Termination Date:
Providence Saint Joseph Medical Center is accredited by California Medical Association (CMA) to provide continuing medical education for physicians. Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
|
|
2/21/2023
|
|
Richard
Wright,
MD.
|
|
Presenter
|
|
Hope Conference Center
|
|
|
Complete Video Confirmation
In order to complete the evaluation, you must log in.
|
Brain Repair After Stroke
|
WEDNESDAY, August 23, 2023
12:15pm – Zoom Live Internet Activity
BRAIN REPAIR AFTER STROKE
STEVEN CRAMER, MD, MMSC, FAAN, FAHA
SUSAN AND DAVID WILSTEIN ENDOWED CHAIR IN REHABILITATION MEDICINE
PROFESSOR, DEPARTMENT OF NEUROLOGY
DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
FACULTY/PLANNER DISCLOSURES: It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Cramer discloses he serves as a consultant for Abbvie, Constant Therapeutics, BrainQ, Myomo, MicroTransponder, Neurolutions, Panaxium, NeuExcell, Elevian, Helius, Omniscient, Brainsgate, Nervgen, Battelle, and TRCare. It is our policy to review presentations ahead of time to mitigate any potential conflicts of interest. There were no conflicts identified in Dr. Cramer’s presentation. Disclosures for the members of the PSJMC Medical Education Committee may be found at https://providencecme.org. No one involved in the planning or presentation of this activity has had any financial relationship or affiliation with an ineligible company in the past 24 months.
This activity was originally sponsored by Providence Little Company of Mary Medical Center, San Pedro.
Release Date: 9/8/23
Review Date: 9/26
Termination Date:
Providence Saint Joseph Medical Center is accredited by California Medical Association (CMA) to provide continuing medical education for physicians. Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
|
|
|
|
|
|
|
|
|